SC
CEMI

Sculptor Capital’s Chembio diagnostics, Inc. CEMI Stock Holding History

Sculptor Capital’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-34,400
Closed -$167K – 591
2020
Q3 		$167K Buy
34,400
+500
+1% +$2.37K ﹤0.01% 316
2020
Q2 		$110K Buy
+33,900
New +$322K ﹤0.01% 263

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital's CEMI Position: Q4 2020 in Review

Sculptor Capital sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2020, closing a stake of 34,400 shares — an estimated $167K sold.

Sculptor Capital first reported a position in CEMI in Q2 2020 and held it in 2 quarters. The position peaked at $167K in Q3 2020. 77 funds tracked by Wall St. Rank hold CEMI as of Q4 2020.

  • Sculptor Capital reported no remaining Chembio diagnostics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Sculptor Capital sold 34,400 Chembio diagnostics, Inc. shares in Q4 2020, an estimated $167K.
  • Sculptor Capital first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 2 quarters.
  • Sculptor Capital's Chembio diagnostics, Inc. position peaked at $167K in Q3 2020.
  • 77 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2020.

Based on Sculptor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.